Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan

被引:37
|
作者
Koike, Teruaki
Tsuchiya, Ryosuke
Goya, Tomoyuki
Sohara, Yasunori
Miyaoka, Etsuo
机构
[1] Niigata Canc Ctr Hosp, Div Chest Surg, Japanese Joint Comm Lung Canc Registrat, Niigata 9518566, Japan
[2] Natl Canc Ctr, Div Thorac Surg, Tokyo, Japan
[3] Kyorin Univ, Dept Surg, Mitaka, Tokyo, Japan
[4] Jichi Med Sch, Dept Surg, Minami Kawachi, Tochigi, Japan
[5] Tokyo Univ Sci, Dept Math, Japanese Joint Comm Lung Canc Registrat, Tokyo 162, Japan
关键词
clinical stage I lung cancer; survival; prognostic factor; limited pulmonary resection; maximum tumor diameter;
D O I
10.1097/01.JTO.0000268674.02744.f9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The objective of this retrospective study was to identify prognostic factors in completely resected clinical (c-) stage I non-small cell lung cancer cases. Methods: In 2001, the Japanese Joint Committee of Lung Cancer Registry collected data on the outcome and clinicopathological profiles of 7408 patients who had undergone resection for primary lung cancer in 1994. They included 3315 c-stage I patients who underwent complete resection, and in this study attempted to identify prognostic factors in the c-stage IA and c-stage IB cases. Results: The overall 5-year survival rate was 66.5%: 74.7% in the 2085 c-stage IA cases and 52.5% in the 1230 c-stage IB cases. The survival curve of the c-stage IA cases was higher than that of the c-stage IB cases. Multivariate analysis of the c-stage IA cases revealed six factors that predicted a significantly better outcome: age, gender, pathological (p-) T status, p-N status, nodal dissection, and tumor diameter (: 2 cm), and the same analysis of the c-stage IB cases revealed six factors: age, gender, p-T status, p-N status operative procedure, and tumor diameter (< 5 cm). The c-stage I patients whose tumor diameter was 2 cm or less had a higher survival rate than the patients whose turner diameter was more than 2 cm, and the c-stage IB patients whose tumor diameter was less than 5 cm had a higher survival rate than the patients whose tumor diameter was 5 cm or more. Conclusion: Tumor size is an independent prognostic factor for postoperative survival in c-stage 1 patients.
引用
收藏
页码:408 / 413
页数:6
相关论文
共 50 条
  • [41] Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
    Yuko Shirata
    Keiichi Jingu
    Masashi Koto
    Masaki Kubozono
    Ken Takeda
    Toshiyuki Sugawara
    Noriyuki Kadoya
    Haruo Matsushita
    Radiation Oncology, 7
  • [42] Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis
    Shirata, Yuko
    Jingu, Keiichi
    Koto, Masashi
    Kubozono, Masaki
    Takeda, Ken
    Sugawara, Toshiyuki
    Kadoya, Noriyuki
    Matsushita, Haruo
    RADIATION ONCOLOGY, 2012, 7
  • [43] Risk factors for bone metastasis in completely resected non-small-cell lung cancer
    Wang, Hui
    Zhang, Yan
    Zhu, Hui
    Yu, Jinming
    FUTURE ONCOLOGY, 2017, 13 (08) : 695 - 704
  • [44] Long-Term Outcome and Late Recurrence in Patients with Completely Resected Stage IA Non-small Cell Lung Cancer
    Maeda, Ryo
    Yoshida, Junji
    Ishii, Genichiro
    Aokage, Keiju
    Hishida, Tomoyuki
    Nishimura, Mitsuyo
    Nishiwaki, Yutaka
    Nagai, Kanji
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (08) : 1246 - 1250
  • [45] Prognostic significance of cancer-testis gene expression in resected non-small cell lung cancer patients
    Melloni, G
    Ferreri, AJM
    Russo, V
    Gattinoni, L
    Arrigoni, G
    Ceresoli, GL
    Zannini, P
    Traversari, C
    ONCOLOGY REPORTS, 2004, 12 (01) : 145 - 151
  • [46] Prognostic implications of cellular senescence in resected non-small cell lung cancer br
    Domen, Andreas
    Deben, Christophe
    De Pauw, Ines
    Hermans, Christophe
    Lambrechts, Hilde
    Verswyvel, Jasper
    Siozopoulou, Vasiliki
    Pauwels, Patrick
    Demaria, Marco
    van de Wiel, Mick
    Janssens, Annelies
    Hendriks, Jeroen M. H.
    Van Schil, Paul
    Vermorken, Jan B.
    Vandamme, Timon
    Prenen, Hans
    Peeters, Marc
    Lardon, Filip
    Wouters, An
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1526 - 1539
  • [47] Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer
    Sakamoto, Jin
    Sonobe, Makoto
    Kobayashi, Masashi
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Nakajima, Daisuke
    Yamada, Tetsu
    Nakayama, Ei
    Takahashi, Tsuyoshi
    Sato, Toshihiko
    Chen, Fengshi
    Bando, Toru
    Date, Hiroshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (01) : 50 - 56
  • [48] Clinical outcomes of stereotactic body radiotherapy for de novo pulmonary tumors in patients with completely resected early stage non-small cell lung cancer
    Zhao, Qianqian
    Chen, Gang
    Ye, Luxi
    Zeng, Zhaochong
    Shi, Shiming
    He, Jian
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 6391 - 6398
  • [49] The ABO Blood Group is an Independent Prognostic Factor in Patients With Resected Non-small Cell Lung Cancer
    Fukumoto, Koichi
    Taniguchi, Tetsuo
    Usami, Noriyasu
    Kawaguchi, Koji
    Fukui, Takayuki
    Ishiguro, Futoshi
    Nakamura, Shota
    Yokoi, Kohei
    JOURNAL OF EPIDEMIOLOGY, 2015, 25 (02) : 110 - 116
  • [50] The Prognostic Impact of Sex on Surgically Resected Non-Small Cell Lung Cancer Depends on Clinicopathologic Characteristics
    Sterlacci, William
    Tzankov, Alexandar
    Veits, Lothar
    Oberaigner, Wilhelm
    Schmid, Thomas
    Hilbe, Wolfgang
    Fiegl, Michael
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2011, 135 (04) : 611 - 618